Related Experiment Video

Updated: Oct 7, 2025

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

9.3K

BRCA2 deficiency increases sensitivity of medulloblastoma to Olaparib by inhibiting RAD51-mediated DNA damage repair

J Yu1, C Zhang1, W Shi1

  • 1Department of Neurosurgery, Children's Hospital of Fudan University, 399 Wanyuan Road, Shanghai, 201102, China.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|January 10, 2022
PubMed
Abstract

Insights

BRCA2 deficiency enhances medulloblastoma cell sensitivity to Olaparib, improving treatment efficacy. This occurs through regulating the RAD51-mediated DNA damage repair pathway, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • BRCA2 mutations are implicated in glioma drug resistance.
  • The role of BRCA2 in medulloblastoma and its impact on chemotherapy response remain unclear.

Purpose of the Study:

  • To investigate the effects of BRCA2 deficiency combined with Olaparib treatment in medulloblastoma.
  • To elucidate the underlying molecular mechanisms.

Main Methods:

  • BRCA2 knockdown using RNAi technology.
  • Cell proliferation assessed via CCK-8 assay and apoptosis via FACS analysis.
  • In vivo efficacy evaluated in xenograft mice models; mechanism explored by Western blotting.

Main Results:

  • BRCA2 knockdown significantly enhanced Olaparib's inhibitory effect on medulloblastoma cell proliferation and increased apoptosis.
  • RAD51 overexpression partially reversed these effects.
  • In vivo studies showed reduced tumor growth with combined Olaparib and BRCA2 knockdown.
  • BRCA2 knockdown modulated DNA damage repair pathways involving RAD51, RAD50, MRE11, and NBS.

Conclusions:

  • BRCA2 deficiency sensitizes medulloblastoma cells to Olaparib, enhancing its therapeutic efficacy both in vitro and in vivo.
  • BRCA2 knockdown impacts DNA damage repair, potentially through the RAD51-mediated signaling pathway.
Keywords:
BRCA2Homologous recombination repairMedulloblastomaOlaparib

More Related Videos

Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

10.4K
Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.2K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
23.4K
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K